I-309/T Cell Activation Gene-3 Chemokine Protects Murine T Cell Lymphomas Against Dexamethasone-Induced Apoptosis

Journal of Immunology

Volumn 157, Issue 6, 1996, Pages 2570-2576

  Van Snick, Jacques ^a,b   Houssiau, Frédéric ^a,b   Proost, Paul ^c   Van Damme, Jo ^c   Renauld, Jean Christophe ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; BORDETELLA VIRULENCE FACTOR; CCL1 PROTEIN, HUMAN; CCL1 PROTEIN, MOUSE; CCR8 PROTEIN, MOUSE; CHEMOKINE; CHEMOTACTIC FACTOR; CYTOKINE; DEXAMETHASONE; PERTUSSIS TOXIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL CULTURE; CHEMOTAXIS; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MOUSE; T CELL LYMPHOMA; T LYMPHOCYTE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CHEMOKINES; CHEMOKINES, CC; CHEMOTACTIC FACTORS; CHEMOTAXIS; CYTOKINES; DEXAMETHASONE; HUMANS; LYMPHOMA, T-CELL; MICE; MICE, TRANSGENIC; PERTUSSIS TOXIN; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; VIRULENCE FACTORS, BORDETELLA;

EID: 0030587071     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Cohen, J. J. 1991. Programmed cell death. Adv. Immunol. 50:55.
2. Gonzalo, J. A., A. Gonzalez-Garcia, C. Martinez, and G. Kroemer. 1993. Glucocorticoid-mediated control of the activation and clonal deletion of peripheral T cells in vivo. J. Exp. Med. 177:1239.
3. McConkey, D. J., P. Hartzell, S. C. Chow, S. Orrenius, and M. Jondal. 1990. Interleukin 1 inhibits T cell receptor-mediated apoptosis in immature thymocytes. J. Biol. Chem. 265:3009.
4. Migliorati, G., I. Nicoletti, M. C. Pagliacci, L. D'Adamio, and C. Riccardi. 1993. Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexamethasone-induced apoptosis. Blood 81:1352.
5. Renauld, J. C., A. Vink, J. Louahed, and J. Van Snick. 1995. Interleukin-9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300.
6. Baggiolini, M., B. Dewald, and B. Moser. 1994. Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97.
7. Shall, T. J. 1991. Biology of the RANTES/SIS cytokine family. Cytokine 3:165.
8. Oppenheim, J. J., C. Zachariae, N. Mukaida, and K. Matsushima. 1991. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9:617.
9. Bacon, K. B., B. A. Premack, P. Gardner, and T. J. Schall. 1995. Activation of dual T cell signalling pathways by the chemokine RANTES. Science 269:1727.
10. +-lymphomas: sensitivity to cortisol and phytohemagglutinin. J. Immunol. 110: 1470.
11. Renauld, J. C., N. van der Lugt, A. Vink, M. van Roon, C. Godfraind, G. Warnier, H. Merz, A. Feller, A. Berns, and J. Van Snick. 1994. Thymic lymphomas in IL-9 transgenic mice. Oncogene 9:1327.
12. Chen, I. S. Y., J. McLaughlin, J. C. Gasson, S. C. Clark, and D. W. Golde. 1983. Molecular characterization of genome of a novel human T cell leukemia virus. Nature 305:502.
13. Avanzi, G. C., P. Lista, B. Giovinazzo, R. Mineiro, G. Saglio, G. Benetton, R. Coda, G. Cattoretti, and L. Pegoraro. 1988. Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br. J. Haematol. 69:359.
14. Houssiau, F., J. C. Renauld, M. Stevens, F. Lehmann, B. Lethé, P. G. Coulie, and J. Van Snick. 1993. Human T cell lines and clones respond to IL-9. J. Immunol. 150:2634.
15. Van Damme, J., P. Proost, J. P. Lenaerts, and G. Opdenakker. 1992. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J. Exp. Med. 176:59.
16. Proost, P., P. Van Leuven, A. Wuyts, R. Ebberink, G. Opdenhakker, and J. Van Damme. 1995. Chemical synthesis, purification and folding of the human monocyte chemotactic proteins MCP-2 and MCP-3 into biologically active chemokines. Cytokine 7:97.
17. Van Snick, J., S. Cayphas, A. Vink, C. Uyttenhove, P. G. Coulie, M. R. Rubira, and R. J. Simpson. 1986. Purification and NH2-terminal amino acid sequence of a T-cell derived lymphokine with growth factor activity for B-cell hybridomas. Proc. Natl. Acad. Sci. USA 83:9679.
18. Landegren, U. 1984. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase: applications to detection of lymphokines and cell surface antigens. J. Immunol. Methods 67:379.
19. Van Damme, J., and R. Conings. 1995. Assays for chemotaxis. In Cytokines, a Practical Approach. F. R. Blackwill, ed. IRL Press, Oxford, U.K., p. 215.
20. Lee, M. R., M. L. Liou, M. L. Liou, Y. F. Yang, and M. Z. Lai. 1993. cAMP analogs prevent activation-induced apoptosis of T cell hybridomas. J. Immunol. 151:5208.
21. Uyttenhove, C., R. Simpson, and J. Van Snick. 1988. Functional and structural characterization of P40, a mouse glycoprotein with T cell growth factor activity. Proc. Natl. Acad. Sci. USA 85:6934.
22. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
23. Morissey, J. H. 1981. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal. Biochem. 117:307.
24. Takebe, T., M. Seiki, J. Fujisawa, P. Hoy, K. Yokota, K. Arai, M. Yoshida, and N. Arai. 1988. SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type I long terminal repeat. Mol. Cell. Biol. 8:466.
25. Miller, M. D., S. Hata, R. de Waal Malefyt, and M. S. Krangel. 1989. A novel polypeptide secreted by activated human T lymphocytes. J. Immunol. 143:2907.
26. Miller, M. D., S. D. Wilson, M. E. Dorf, H. N. Seuanez, S. J. O'Brien, and M. S. Krangel. 1990. Sequence and chromosomal location of the I-309 gene: relationship to genes encoding a family of inflammatory cytokines. J. Immunol. 145: 2737.
27. Brown, K. D., S. M. Zurawski, T. R. Mosmann, and G. Zurawski. 1989. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol. 142: 679.
28. Burd, P. R., G. J. Freeman, S. D. Wilson, M. Berman, R. DeKruyff, P. R. Billings, and M. E. Dorf. 1987. Cloning and characterization of a novel T cell activation gene. J. Immunol. 139:3126.
29. Wilson, S. D., V. K. Kuchroo, D. I. Israel, and M. E. Dorf. 1990. Expression and characterization of TCA-3: a murine inflammatory protein. J. Immunol. 145: 2745.
30. Devi, S., J. Laning, Y. Luo, and M. E. Dorf. 1995. Biologic activities of the β-chemokine TCA-3 on neutrophils and macrophages. J. Immunol. 154:5376.
31. Miller, M. D., and M. S. Krankel. 1992. The human cytokine I309 is a monocyte chemoattractant. Proc. Natl. Acad. Sci. USA 89:2950.
32. Vint, A., J. C. Renauld, G. Warnier, and J. Van Snick. 1993. Interleukin 9 stimulates in vitro growth of mouse thymic lymphomas. Eur. J. Immunol. 23: 1134.
33. + T cells but is not a general T cell growth factor. Eur. J. Immunol. 19:2167.
34. Suda, T., R. Murray, M. Fischer, T. Tokota, and A. Zlotnik. 1990. Tumor necrosis factor-a and P40 induce day 15 murine fetal thymocyte proliferation in combination with IL-2. J. Immunol. 144:1783.